Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

Dishman Carbogen Amcis

Sector: Healthcare | Industry: Drugs & Pharma
R 151.90 -3.30  | -2.13% -30.88% 11.94 2,454.00
NSE Price: Oct 22, 15:57 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Oct 22, 15:57 151.90 -3.30 -2.13% 156.85 155.20 84,837 150.10 - 158.85
BSE Oct 22, 2019 152.05 -3.30 -2.12% 155.80 155.35 5,845 150.15 - 158.50
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 118,096 P/B: 0.45 NSE Code: DCAL
52-Week Range: R 150.10 - 257.50 Dividend Yield: 0.13% BSE Code: 540701
TTM EPS: R 12.73 Book Value: R 335.41 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Dishman Carbogen Amcis -34.11 -14.59 -27.04 -30.88 - - -
S&P BSE Small Cap -10.31 -0.11 0.26 -4.45 -0.60 4.66 5.60
S&P BSE Healthcare -7.84 -1.42 0.06 -11.61 -7.74 -1.50 11.51
Company's return has been calculated on basis of NSE's price.
As on Oct 22, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 15.81 332.11 -
Net Profit 51.09 297.76 233.79
EPS 51.09 -53.98 16.30
Book Value 2.10 184.24 89.46
Average
Unable to fetch data.
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -19.67 8.22 -19.67
Operating Profit -32.74 0.30 -32.74
Net Profit -54.73 -13.45 -54.73
EPS -54.73 -13.44 -54.73
TTM
Revenue 1.93 14.20 1.93
Operating Profit 0.06 11.97 0.06
Net Profit -2.53 13.42 -2.53
EPS -2.53 13.42 -2.53
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Dishman Carbogen Amcis 2,454.00 2,098.27 205.48 9.54 4.01 0.45 11.94
Astrazeneca Pharma India 6,030.25 771.42 69.56 8.84 20.03 18.83 86.69
Eris Lifesciences 5,850.09 1,005.70 303.64 29.29 28.96 4.74 19.27
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jan 28, 2019 Adimans Technologies LLP  Buy Others 99,091,898 210.75 208,836.18
Jan 28, 2019 Adimans Technologies Pvt Ltd  Sell Others 99,091,898 210.75 208,836.18
Dec 01, 2018 M/s Adimans Technologies Pvt Ltd  Buy Scheme of Amalgamation/Merger/Demerger/Arrangement 99,091,898 238.30 236,135.99
Dec 01, 2018 M/s Bhadra Raj Holdings Pvt Ltd  Sell Scheme of Amalgamation/Merger/Demerger/Arrangement 99,091,898 238.30 236,135.99
Fund Houses invested in the stock
Fund Sep-19 Jun-19 Mar-19 Dec-18 Sep-18
Tata Mutual Fund 3.159 3.159 3.159 3.159 2.933
ICICI Prudential Mutual Fund 3.121 2.749 2.790 2.452 1.907
IDFC Mutual Fund 2.835 2.853 2.773 2.497 2.422
Aditya Birla Sun Life Mutual Fund 1.574 1.375 1.503 1.342 1.342
L&T Mutual Fund 0.662 0.664 0.796 1.248 1.068
Principal Mutual Fund 0.527 0.526 0.532 0.445 0.394
Canara Robeco Mutual Fund 0.215 0.556 0.110 - -
IDBI Mutual Fund 0.063 0.063 0.063 0.063 0.056
Motilal Oswal Mutual Fund 0.001 - - - -
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Dishman Carbogen Amcis Ltd.

Address: Bhadr- Raj Chambers, Swastik Cross Roads, Navrangpura, Ahmedabad, Gujarat - 380009 | Phone: 02717 420102

Email: [email protected]

Website: www.dishmangroup.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra, C 101, 247 Park, LBS Marg, Vikhroli (West) | Phone: 91-022-49186000/49186270 | Fax: 91-022-49186060

Email: [email protected]

Website: www.linkintime.co.in

Essential checks
Altman Z-Score
2.28
Piotroski F-Score
8
Modified C-Score
0
1-Year Price to Earnings
11.94
1-Year Price to Book
0.45
Earnings Yield
EBIT / Enterprise value
10.44%
PEG
Price / Earnings to growth ratio
0.11
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,412.00 +5.87%
Caplin Point Laboratories R387.75 -2.29%
Eris Lifesciences R425.40 +0.66%
FDC R160.95 +0.03%
JB Chemicals & Pharma R359.80 -1.84%
Laurus Labs R341.70 +8.06%
Strides Pharma Science R350.75 -0.88%
Sun Pharma Adv. Research R132.60 +0.08%
Suven Life Sciences R286.65 +2.17%
Wockhardt R275.20 +3.28%
As on Oct 22, 15:59